CoChat

CD44 connects autophagy decline and ageing in the vascular endothelium

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

The decline of endothelial autophagy is closely related to vascular senescence and disease, although the molecular mechanisms connecting these outcomes in vascular endothelial cells (VECs) remain unclear. Here, we identify a crucial role for CD44, a multifunctional adhesion molecule, in controlling autophagy and ageing in VECs. The CD44 intercellular domain (CD44ICD) negatively regulates autophagy by reducing PIK3R4 and PIK3C3 levels and disrupting STAT3-dependent PtdIns3K complexes. CD44 and its homologue clec-31 are increased in ageing vascular endothelium and Caenorhabditis elegans, respectively, suggesting that an age-dependent increase in CD44 induces autophagy decline and ageing phenotypes. Accordingly, CD44 knockdown ameliorates age-associated phenotypes in VECs. The endothelium-specific CD44ICD knock-in mouse is shorter-lived, with VECs exhibiting obvious premature ageing characteristics associated with decreased basal autophagy. Autophagy activation suppresses the premature ageing of human and mouse VECs overexpressing CD44ICD, function conserved in the CD44 homologue clec-31 in C. elegans. Our work describes a mechanism coordinated by CD44 function bridging autophagy decline and ageing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-41346-y

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CD44 exhibits age-related upregulation and contributes to VEC senescence. a SA-β-gal staining in primary HUVECs with indicated population doubling (PD). Bar = 50 μm. b, c Western blot (b) and qRT-PCR (c) analysis of CD44, CDKN1A and CDKN2A in primary HUVECs with indicated PD. d, e Western blot (d) and qRT-PCR (e) analysis of aortas obtained from young (2–4 months), middled-aged (8-12 months), and aged (≥19 months) C57BL/6 mice. f En face staining for CD44 of aortas obtained from different age of C57BL/6 mice. MFI, mean fluorescence intensity. Bar = 20 μm. Green, CD31; Red, CD44. g Immunohistochemical staining for CD44 of aortas obtained from different age of C57BL/6 mice. h, i SA-β-gal staining (h) and western blot analysis of CD44, CDKN1A and CDKN2A (i) in HUVECs (PD14-PD18) expressing non-targeting control shRNA (shNTC) or shCD44. Bar = 30 μm. j, k SA-β-gal staining (j) and western blot analysis of CD44, CDKN1A and CDKN2A (k) in HUVECs (PD3-PD6) transduced with empty vector (Ev) or CD44. l, m, n, r En face SA-β-gal staining (l) or immunohistochemical staining for CDKN1A (m), CDKN2A (n) and p-eNOS (r) of aortas obtained from WT (C57BL/6) or CD44-KO mice (16–19 months). o–q H&E staining (o), elastin staining (p) and Masson Tricolor staining (q) of aortic sections obtained from WT or CD44-KO mice (16–19 months). Bar = 200 μm. Bar in zoomed figure = 50 μm (l–q). s Serum NO level of WT or CD44-KO mice (16–19 months). For d, n = 12 mice per group. For e, n = 4 mice per group. For f, n = 7 (young or aged) or 6 (middle-aged) mice. For g, l, m, n, r, n = 5 mice per group. For o, p, q, s, n = 6 mice per group. Two (d–g, l–s) or three (a, c, h–k) or four (b) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Tukey’s multiple comparisons test (a–g), Two-tailed unpaired Student’s t-tests (h–s). Source data are provided as a Source data file.
Fig. 1 CD44 exhibits age-related upregulation and contributes to VEC senescence. a SA-β-gal staining in primary HUVECs with indicated population doubling (PD). Bar = 50 μm. b, c Western blot (b) and qRT-PCR (c) analysis of CD44, CDKN1A and CDKN2A in primary HUVECs with indicated PD. d, e Western blot (d) and qRT-PCR (e) analysis of aortas obtained from young (2–4 months), middled-aged (8-12 months), and aged (≥19 months) C57BL/6 mice. f En face staining for CD44 of aortas obtained from different age of C57BL/6 mice. MFI, mean fluorescence intensity. Bar = 20 μm. Green, CD31; Red, CD44. g Immunohistochemical staining for CD44 of aortas obtained from different age of C57BL/6 mice. h, i SA-β-gal staining (h) and western blot analysis of CD44, CDKN1A and CDKN2A (i) in HUVECs (PD14-PD18) expressing non-targeting control shRNA (shNTC) or shCD44. Bar = 30 μm. j, k SA-β-gal staining (j) and western blot analysis of CD44, CDKN1A and CDKN2A (k) in HUVECs (PD3-PD6) transduced with empty vector (Ev) or CD44. l, m, n, r En face SA-β-gal staining (l) or immunohistochemical staining for CDKN1A (m), CDKN2A (n) and p-eNOS (r) of aortas obtained from WT (C57BL/6) or CD44-KO mice (16–19 months). o–q H&E staining (o), elastin staining (p) and Masson Tricolor staining (q) of aortic sections obtained from WT or CD44-KO mice (16–19 months). Bar = 200 μm. Bar in zoomed figure = 50 μm (l–q). s Serum NO level of WT or CD44-KO mice (16–19 months). For d, n = 12 mice per group. For e, n = 4 mice per group. For f, n = 7 (young or aged) or 6 (middle-aged) mice. For g, l, m, n, r, n = 5 mice per group. For o, p, q, s, n = 6 mice per group. Two (d–g, l–s) or three (a, c, h–k) or four (b) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Tukey’s multiple comparisons test (a–g), Two-tailed unpaired Student’s t-tests (h–s). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 2 CD44 negatively regulates autophagy. a, b Western blot analysis of LC3B-II/LC3B-I and SQSTM1 (a) or immunohistochemical staining for SQSTM1 (b) of aortas obtained from WT or CD44-KO mice (16–19 months) treated with vehicle or chloroquine (CQ) by daily intraperitoneal injection (60 mg/kg/day) for 4 days. Bar = 200 μm. Bar in zoomed figure = 50 μm. c, g Fluorescence analysis of GFP-LC3B puncta in HUVECs (PD3-6) transfected with scrambled siRNA or CD44 siRNAs (c), or transduced with Ev or CD44ICD (g) in the presence or absence of bafilomycin A1 (100 nM) for 6 h. d, h Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-6) transfected with scrambled siRNA or CD44 siRNAs (d), or transduced with Ev or CD44 (h) in the presence or absence of bafilomycin A1 (100 nM) for 6 h. e, j Fluorescence analysis of CD44 knockdown (e) or CD44ICD-overxpressing (j) HUVECs (PD3-PD6) transfected with mCherry-GFP-LC3B reporter. HUVECs treated with bafilomycin A1 (100 nM) for 6 h were used as a positive control for impaired autophagic flux. HUVECs incubated with EBSS for 3 h or treated with rapamycin (100 nM) for 6 h were used as positive controls for enhanced autophagy activity. Nuclei were stained with DAPI. Quantification of the average number of autolysosomes (GFP−mCherry+ puncta, red) and autophagosomes (GFP+mCherry+ puncta, yellow) per cell. Bar = 10 μm. f, i Ultrastructural analysis of HUVECs (PD3-6) transfected with scrambled siRNA or CD44 siRNAs (f), or transduced with Ev or CD44 (i). Bar = 500 nm. Boxed areas are enlarged below each image. For a, n = 6 (left bar graph) or 7 (right bar graph) mice per group. For b, n = 5 mice per group. Two (a, b) or three (c–g, j) or four (h) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Two-tailed unpaired Student’s t-tests (a, b), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (c–e, g, h, j). Source data are provided as a Source data file.
Fig. 2 CD44 negatively regulates autophagy. a, b Western blot analysis of LC3B-II/LC3B-I and SQSTM1 (a) or immunohistochemical staining for SQSTM1 (b) of aortas obtained from WT or CD44-KO mice (16–19 months) treated with vehicle or chloroquine (CQ) by daily intraperitoneal injection (60 mg/kg/day) for 4 days. Bar = 200 μm. Bar in zoomed figure = 50 μm. c, g Fluorescence analysis of GFP-LC3B puncta in HUVECs (PD3-6) transfected with scrambled siRNA or CD44 siRNAs (c), or transduced with Ev or CD44ICD (g) in the presence or absence of bafilomycin A1 (100 nM) for 6 h. d, h Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-6) transfected with scrambled siRNA or CD44 siRNAs (d), or transduced with Ev or CD44 (h) in the presence or absence of bafilomycin A1 (100 nM) for 6 h. e, j Fluorescence analysis of CD44 knockdown (e) or CD44ICD-overxpressing (j) HUVECs (PD3-PD6) transfected with mCherry-GFP-LC3B reporter. HUVECs treated with bafilomycin A1 (100 nM) for 6 h were used as a positive control for impaired autophagic flux. HUVECs incubated with EBSS for 3 h or treated with rapamycin (100 nM) for 6 h were used as positive controls for enhanced autophagy activity. Nuclei were stained with DAPI. Quantification of the average number of autolysosomes (GFP−mCherry+ puncta, red) and autophagosomes (GFP+mCherry+ puncta, yellow) per cell. Bar = 10 μm. f, i Ultrastructural analysis of HUVECs (PD3-6) transfected with scrambled siRNA or CD44 siRNAs (f), or transduced with Ev or CD44 (i). Bar = 500 nm. Boxed areas are enlarged below each image. For a, n = 6 (left bar graph) or 7 (right bar graph) mice per group. For b, n = 5 mice per group. Two (a, b) or three (c–g, j) or four (h) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Two-tailed unpaired Student’s t-tests (a, b), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (c–e, g, h, j). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 3 CD44 reduced autophagy via its ICD. a Schematic of the CD44 domain deletion mutants. b,c, Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev, CD44ΔICD and CD44ICD (b), or CD44ECD and CD44ΔECD (c). d Ultrastructural analysis of HUVECs (PD3-PD6) transduced with Ev, CD44ΔICD, CD44ICD, CD44ECD or CD44ΔECD. Boxed areas are enlarged below each image. Bar = 1 μm. e Fluorescence analysis of Ev or CD44ICD-overxpressing HUVECs (PD3-PD6) transfected with mCherry-GFP-LC3B reporter. Nuclei were stained with DAPI. Bar = 10 μm. f Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev or CD44ICD in the presence or absence of bafilomycin A1 (100 nM) for 6 h. g Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in CD44KO HUVECs, reconstituted CD44KO/CD44 HUVECs and reconstituted CD44KO/CD44ICD HUVECs. h Constructs used to generate the endothelium-specific CD44ICD-KI mouse model. ROSA26CD44ICDKI mice (genotype: CD44ICDflox/flox) were crossed with endothelial-specific receptor tyrosine kinase (Tek) Cre mice to generate CD44ICDEC-KI mice (genotype: CD44ICDflox/flox:Tek-Cre). i, j En face staining (i) or immunohistochemical staining (j) for LC3B and SQSTM1 of the aortas from WT (CD44ICDflox/flox) and CD44ICDEC-KI (CD44ICDflox/flox:Tek-Cre) mice (8–10 months). Bar = 50 μm. i Green, CD31; Red, LC3B or SQSTM1. j Green, autofluorescence of the internal elastic lamina; Red, LC3B or SQSTM1. k Western blot analysis of LC3B-II/LC3B-I and SQSTM1 of aortas obtained from WT (CD44ICDflox/flox) and CD44ICDEC-KI (8–10 months) treated with vehicle or CQ by daily intraperitoneal injection (60 mg/kg/day) for 4 days. For i, j, n = 5 mice per group. For k, n = 5 (left bar graph) or 4 (right bar graph) mice per group. Two (i–k) or three (d, e, f) or four (b, c, g) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Dunnett’s multiple comparisons test (b, c), Two-tailed unpaired Student’s t-tests (e, f, i–k), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (g). Source data are provided as a Source data file.
Fig. 3 CD44 reduced autophagy via its ICD. a Schematic of the CD44 domain deletion mutants. b,c, Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev, CD44ΔICD and CD44ICD (b), or CD44ECD and CD44ΔECD (c). d Ultrastructural analysis of HUVECs (PD3-PD6) transduced with Ev, CD44ΔICD, CD44ICD, CD44ECD or CD44ΔECD. Boxed areas are enlarged below each image. Bar = 1 μm. e Fluorescence analysis of Ev or CD44ICD-overxpressing HUVECs (PD3-PD6) transfected with mCherry-GFP-LC3B reporter. Nuclei were stained with DAPI. Bar = 10 μm. f Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev or CD44ICD in the presence or absence of bafilomycin A1 (100 nM) for 6 h. g Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in CD44KO HUVECs, reconstituted CD44KO/CD44 HUVECs and reconstituted CD44KO/CD44ICD HUVECs. h Constructs used to generate the endothelium-specific CD44ICD-KI mouse model. ROSA26CD44ICDKI mice (genotype: CD44ICDflox/flox) were crossed with endothelial-specific receptor tyrosine kinase (Tek) Cre mice to generate CD44ICDEC-KI mice (genotype: CD44ICDflox/flox:Tek-Cre). i, j En face staining (i) or immunohistochemical staining (j) for LC3B and SQSTM1 of the aortas from WT (CD44ICDflox/flox) and CD44ICDEC-KI (CD44ICDflox/flox:Tek-Cre) mice (8–10 months). Bar = 50 μm. i Green, CD31; Red, LC3B or SQSTM1. j Green, autofluorescence of the internal elastic lamina; Red, LC3B or SQSTM1. k Western blot analysis of LC3B-II/LC3B-I and SQSTM1 of aortas obtained from WT (CD44ICDflox/flox) and CD44ICDEC-KI (8–10 months) treated with vehicle or CQ by daily intraperitoneal injection (60 mg/kg/day) for 4 days. For i, j, n = 5 mice per group. For k, n = 5 (left bar graph) or 4 (right bar graph) mice per group. Two (i–k) or three (d, e, f) or four (b, c, g) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Dunnett’s multiple comparisons test (b, c), Two-tailed unpaired Student’s t-tests (e, f, i–k), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (g). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 4 CD44-mediated autophagy reduction requires CD44ICD release rather than nuclear translocation. a, e Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev, CD44Δ287-290 (a) or Myr-CD44ICD (e). b, f Fluorescence analysis of GFP-LC3B puncta in HUVECs transduced with Ev, CD44Δ287-290 (b) or Myr-CD44ICD (f). Nuclei were stained with DAPI. Bar = 10 μm. c, g Ultrastructural analysis of HUVECs (PD3-PD6) transduced with Ev, CD44Δ287-290 (c) or Myr-CD44ICD (g). Boxed area of each image is enlarged to the right. Asterisks indicate the autophagosomes/autolysosomes. Bar = 1 μm. d Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev, CD44 or CD44ICD in the presence or absence GSI (5 μM) for 3 h. Three biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Two-tailed unpaired Student’s t-tests (a, b, e, f), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (d). Source data are provided as a Source data file.
Fig. 4 CD44-mediated autophagy reduction requires CD44ICD release rather than nuclear translocation. a, e Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev, CD44Δ287-290 (a) or Myr-CD44ICD (e). b, f Fluorescence analysis of GFP-LC3B puncta in HUVECs transduced with Ev, CD44Δ287-290 (b) or Myr-CD44ICD (f). Nuclei were stained with DAPI. Bar = 10 μm. c, g Ultrastructural analysis of HUVECs (PD3-PD6) transduced with Ev, CD44Δ287-290 (c) or Myr-CD44ICD (g). Boxed area of each image is enlarged to the right. Asterisks indicate the autophagosomes/autolysosomes. Bar = 1 μm. d Western blot analysis of LC3B-II/LC3B-I and SQSTM1 in HUVECs (PD3-PD6) transduced with Ev, CD44 or CD44ICD in the presence or absence GSI (5 μM) for 3 h. Three biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Two-tailed unpaired Student’s t-tests (a, b, e, f), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (d). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 5 CD44ICD reduces the level and activity of the PtdIns3K complex. a, b qRT-PCR analysis of the core proteins of the PtdIns3K complexes in HUVECs (PD3-PD6) transfected with scrambled siRNA and CD44 siRNAs (a), or transduced with Ev and CD44ICD (b). c, d Western blot analysis of the core proteins of the PtdIns3K complexes in HUVECs (PD3-PD6) transfected with scrambled siRNA or CD44 siRNAs (c), or transduced with Ev, CD44 and CD44ICD (d). e Endogenous ATG14L was immunoprecipitated from HUVECs and used for in vitro ELISA based PIK3C3 kinase activity assay. Different PtdIns3K complex components from Ev, CD44 or CD44ICD transfected HUVECs were immunoprecipitated using the ATG14L antibody. PIK3C3 activity was measured by analyzing PtdIns3P production in the ELISA assay described in the “Methods” section. The PtdIns3P fold change was calculated based on the concentration of PtdIns3P and was normalized to the amount of ATG14L used in the assay. Values are quantified minus IgG control reaction values. Three (c–e) or four (a, b) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Dunnett’s multiple comparisons test (a, c–e), Two-tailed unpaired Student’s t-tests (b). Source data are provided as a Source data file.
Fig. 5 CD44ICD reduces the level and activity of the PtdIns3K complex. a, b qRT-PCR analysis of the core proteins of the PtdIns3K complexes in HUVECs (PD3-PD6) transfected with scrambled siRNA and CD44 siRNAs (a), or transduced with Ev and CD44ICD (b). c, d Western blot analysis of the core proteins of the PtdIns3K complexes in HUVECs (PD3-PD6) transfected with scrambled siRNA or CD44 siRNAs (c), or transduced with Ev, CD44 and CD44ICD (d). e Endogenous ATG14L was immunoprecipitated from HUVECs and used for in vitro ELISA based PIK3C3 kinase activity assay. Different PtdIns3K complex components from Ev, CD44 or CD44ICD transfected HUVECs were immunoprecipitated using the ATG14L antibody. PIK3C3 activity was measured by analyzing PtdIns3P production in the ELISA assay described in the “Methods” section. The PtdIns3P fold change was calculated based on the concentration of PtdIns3P and was normalized to the amount of ATG14L used in the assay. Values are quantified minus IgG control reaction values. Three (c–e) or four (a, b) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Dunnett’s multiple comparisons test (a, c–e), Two-tailed unpaired Student’s t-tests (b). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 6 CD44ICD alters the assembly state of PtdIns3K complex via STAT3. a Fluorescence analysis of the colocalization of CD44ICD with endogenous STAT3 and core proteins of the PtdIns3K complexes in HUVECs transduced with Ev or CD44ICD. Nuclei were stained with DAPI. Bar = 10 μm. The line scanned profiles at the right of confocal images show the distribution of fluorescence for each channel in the white line in the corresponding confocal images. b Reactivity of CD44ICD or STAT3 with PtdIns3K complex proteins, and STAT3 with CD44ICD in a yeast two-hybrid system. Yeast strain AH109 was co-transformed with a bait plasmid, BD-CD44ICD or BD-STAT3, and a prey plasmid, pGADT7-PtdIns3K complex proteins (AD-ATG14L, AD-BECN1, AD-UVRAG, AD-PIK3C3, and AD-PIK3R4) or pGADT7-CD44ICD, which encodes PtdIns3K complex proteins or CD44ICD fused to the Gal4 activation domain. Co-transformation of BD-Lam/AD-T and BD-P53/AD-T was used as negative and positive controls, respectively. c BiFC analysis of CD44ICD-STAT3 and STAT3-PIK3R4 interactions. HUVECs were transfected with indicated combinations of constructs. Co-transfection of VN-Jun and VC-Fos was used as positive control. Bar = 30 μm. d, e GST-pull-down of recombinant STAT3 with a GST-CD44ICD fusion protein (d) or a GST-P150 domain fusion protein (e). f The binding mode of full-sequence structures of STAT3 and CD44ICD. Colors indicate: STAT3, green; CD44ICD, red. The key residues interacting between STAT3 and CD44ICD are indicated as gray and yellow, respectively. Hydrogen bond is described by pink dash lines. g Western blots showing co-IP of CD44ICD_ΔN35 with endogenous STAT3 and core proteins of the PtdIns3K complexes in HUVECs transduced with Ev or CD44ICD_ΔN35 (DDK tag). Lysates, whole cell lysates; IP, immunoprecipitates. h Proposed schematic diagram of CD44ICD-mediated autophagy decline. CD44ICD suppresses the levels of PIK3C3 and PIK3R4 and the kinase activity of PIK3C3, activates STAT3, and disrupts the assembly of the PtdIns3K complex by interacting with STAT3. Three biologically independent experiments. Source data are provided as a Source data file.
Fig. 6 CD44ICD alters the assembly state of PtdIns3K complex via STAT3. a Fluorescence analysis of the colocalization of CD44ICD with endogenous STAT3 and core proteins of the PtdIns3K complexes in HUVECs transduced with Ev or CD44ICD. Nuclei were stained with DAPI. Bar = 10 μm. The line scanned profiles at the right of confocal images show the distribution of fluorescence for each channel in the white line in the corresponding confocal images. b Reactivity of CD44ICD or STAT3 with PtdIns3K complex proteins, and STAT3 with CD44ICD in a yeast two-hybrid system. Yeast strain AH109 was co-transformed with a bait plasmid, BD-CD44ICD or BD-STAT3, and a prey plasmid, pGADT7-PtdIns3K complex proteins (AD-ATG14L, AD-BECN1, AD-UVRAG, AD-PIK3C3, and AD-PIK3R4) or pGADT7-CD44ICD, which encodes PtdIns3K complex proteins or CD44ICD fused to the Gal4 activation domain. Co-transformation of BD-Lam/AD-T and BD-P53/AD-T was used as negative and positive controls, respectively. c BiFC analysis of CD44ICD-STAT3 and STAT3-PIK3R4 interactions. HUVECs were transfected with indicated combinations of constructs. Co-transfection of VN-Jun and VC-Fos was used as positive control. Bar = 30 μm. d, e GST-pull-down of recombinant STAT3 with a GST-CD44ICD fusion protein (d) or a GST-P150 domain fusion protein (e). f The binding mode of full-sequence structures of STAT3 and CD44ICD. Colors indicate: STAT3, green; CD44ICD, red. The key residues interacting between STAT3 and CD44ICD are indicated as gray and yellow, respectively. Hydrogen bond is described by pink dash lines. g Western blots showing co-IP of CD44ICD_ΔN35 with endogenous STAT3 and core proteins of the PtdIns3K complexes in HUVECs transduced with Ev or CD44ICD_ΔN35 (DDK tag). Lysates, whole cell lysates; IP, immunoprecipitates. h Proposed schematic diagram of CD44ICD-mediated autophagy decline. CD44ICD suppresses the levels of PIK3C3 and PIK3R4 and the kinase activity of PIK3C3, activates STAT3, and disrupts the assembly of the PtdIns3K complex by interacting with STAT3. Three biologically independent experiments. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 7 Activation of autophagy reverses premature ageing of CD44ICD-overexpressing VECs. a–c En face SA-β-gal staining (a) or immunohistochemical staining for CDKN1A (b) and CDKN2A (c) of aortas obtained from WT (CD44ICDflox/flox) and CD44ICDEC-KI mice (8–10 months). Bar = 100 μm. Green, CD31; Red, CDKN1A and CDKN2A. d–f H&E staining (h), Masson Tricolor staining (i) or elastin staining (j) of aortic sections obtained from WT and CD44ICDEC-KI mice (8–10 months). Bar = 150 μm. Bar in zoomed figure = 50 μm. g–i Echocardiography assessment of systolic (S) and diastolic (D) aortic arch lumen diameter (j) and abdominal aorta lumen diameter (h), and peak velocity of blood flow at the aortic arch (i) in WT and CD44ICDEC-KI mice (14–17 months). j, k SA-β-gal staining (j) and western blot analysis of CDKN1A and CDKN2A (k) in HUVECs (PD3-PD6) transduced with Ev or CD44ICD. Bar = 30 μm. i, m, n En face SA-β-gal staining (i) or immunohistochemical staining for CDKN1A (m) and CDKN2A (n) of aortas from CD44ICDEC-KI mice (8 months) received intraperitoneal injection of vehicle and rapamycin once every 2 days for a total of 6 injections (4 mg/kg/day), or fed with trehalose for 25 days (administration of 2% trehalose in drinking water). Bar = 150 μm. Bar in zoomed figure = 50 μm. o, p SA-β-gal staining (o) and western blot analysis of CDKN1A and CDKN2A (p) in CD44ICD-overexpressing HUVECs (PD2) treated with rapamycin (1 nM) or trehalose (100 μM) for 15 days. Bar = 30 μm. For a, n = 6 mice per group. For b, c, n = 10 mice per group. For d, e, f, l, m, n, n = 5 mice per group. For g, h, i, n = 11 (WT) mice, n = 10 (CD44ICDEC-KI) mice. Two (a–i, l–n) or three (j, k, p) or four (o) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Two-tailed unpaired Student’s t-tests (a–k), one-way ANOVA with Dunnett’s multiple comparisons test (l–p). Source data are provided as a Source data file.
Fig. 7 Activation of autophagy reverses premature ageing of CD44ICD-overexpressing VECs. a–c En face SA-β-gal staining (a) or immunohistochemical staining for CDKN1A (b) and CDKN2A (c) of aortas obtained from WT (CD44ICDflox/flox) and CD44ICDEC-KI mice (8–10 months). Bar = 100 μm. Green, CD31; Red, CDKN1A and CDKN2A. d–f H&E staining (h), Masson Tricolor staining (i) or elastin staining (j) of aortic sections obtained from WT and CD44ICDEC-KI mice (8–10 months). Bar = 150 μm. Bar in zoomed figure = 50 μm. g–i Echocardiography assessment of systolic (S) and diastolic (D) aortic arch lumen diameter (j) and abdominal aorta lumen diameter (h), and peak velocity of blood flow at the aortic arch (i) in WT and CD44ICDEC-KI mice (14–17 months). j, k SA-β-gal staining (j) and western blot analysis of CDKN1A and CDKN2A (k) in HUVECs (PD3-PD6) transduced with Ev or CD44ICD. Bar = 30 μm. i, m, n En face SA-β-gal staining (i) or immunohistochemical staining for CDKN1A (m) and CDKN2A (n) of aortas from CD44ICDEC-KI mice (8 months) received intraperitoneal injection of vehicle and rapamycin once every 2 days for a total of 6 injections (4 mg/kg/day), or fed with trehalose for 25 days (administration of 2% trehalose in drinking water). Bar = 150 μm. Bar in zoomed figure = 50 μm. o, p SA-β-gal staining (o) and western blot analysis of CDKN1A and CDKN2A (p) in CD44ICD-overexpressing HUVECs (PD2) treated with rapamycin (1 nM) or trehalose (100 μM) for 15 days. Bar = 30 μm. For a, n = 6 mice per group. For b, c, n = 10 mice per group. For d, e, f, l, m, n, n = 5 mice per group. For g, h, i, n = 11 (WT) mice, n = 10 (CD44ICDEC-KI) mice. Two (a–i, l–n) or three (j, k, p) or four (o) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Two-tailed unpaired Student’s t-tests (a–k), one-way ANOVA with Dunnett’s multiple comparisons test (l–p). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 8 C. elegans CD44 homologue clec-31 regulates autophagy, ageing and longevity. a Detection of GFP::LGG1 puncta in nematodes fed RNAi bacteria targeting empty vector or clec-31. Nematodes that were treated with rapamycin (100 μM) were used as a positive control. Bar = 100 μm. Bar in zoomed figure = 50 μm. b, c qRT-PCR analysis of a panel of autophagy-related genes in nematodes fed RNAi bacteria targeting empty vector or clec-31 (b) or in clec-31-overexpressing (OE) nematodes (c). d qRT-PCR analysis of clec-31 in nematodes aged different days as indicated in the figure. e, i Survival curves of (e) nematodes fed RNAi bacteria targeting empty vector, clec-31 or treated with rapamycin as a positive control, (i) WT and clec-31-OE nematodes. All lines were raised and maintained at 20 °C. f, j The number of body bends monitored during a 30 s interval in (f) nematodes fed RNAi bacteria targeting empty vector or clec-31, j WT and clec-31-OE nematodes. g, k The number of pumps monitored during a 30 s interval in (g) nematodes fed RNAi bacteria targeting empty vector or clec-31, (k) WT and clec-31-OE nematodes. h, l Detection of lipofuscin autofluorescence in (h) nematodes fed RNAi bacteria targeting empty vector or clec-31, l WT and clec-31-OE nematodes. For a, n = 23 (WT control RNAi or Rapamycin) nematodes, n = 25 (clec-31 RNAi) nematodes. For e, n = 100 nematodes per group. For f, g, j, k, n = 30 nematodes per group. For h, n = 24 (WT control RNAi) nematodes, n = 23 (clec-31 RNAi) nematodes, n = 22 (Rapamycin) nematodes. For i, n = 109 nematodes per group. For l, n = 27 (WT control) nematodes, n = 24 (clec-31-OE) nematodes. Three (a, d, e–l) or four (b, c) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Dunnett’s multiple comparisons test (a, h), Two-tailed unpaired Student’s t-tests (b, c, f, g, j–l), one-way ANOVA with Tukey’s multiple comparisons test (d), Log-rank (Mantel-Cox) test (e, i). Source data are provided as a Source data file.
Fig. 8 C. elegans CD44 homologue clec-31 regulates autophagy, ageing and longevity. a Detection of GFP::LGG1 puncta in nematodes fed RNAi bacteria targeting empty vector or clec-31. Nematodes that were treated with rapamycin (100 μM) were used as a positive control. Bar = 100 μm. Bar in zoomed figure = 50 μm. b, c qRT-PCR analysis of a panel of autophagy-related genes in nematodes fed RNAi bacteria targeting empty vector or clec-31 (b) or in clec-31-overexpressing (OE) nematodes (c). d qRT-PCR analysis of clec-31 in nematodes aged different days as indicated in the figure. e, i Survival curves of (e) nematodes fed RNAi bacteria targeting empty vector, clec-31 or treated with rapamycin as a positive control, (i) WT and clec-31-OE nematodes. All lines were raised and maintained at 20 °C. f, j The number of body bends monitored during a 30 s interval in (f) nematodes fed RNAi bacteria targeting empty vector or clec-31, j WT and clec-31-OE nematodes. g, k The number of pumps monitored during a 30 s interval in (g) nematodes fed RNAi bacteria targeting empty vector or clec-31, (k) WT and clec-31-OE nematodes. h, l Detection of lipofuscin autofluorescence in (h) nematodes fed RNAi bacteria targeting empty vector or clec-31, l WT and clec-31-OE nematodes. For a, n = 23 (WT control RNAi or Rapamycin) nematodes, n = 25 (clec-31 RNAi) nematodes. For e, n = 100 nematodes per group. For f, g, j, k, n = 30 nematodes per group. For h, n = 24 (WT control RNAi) nematodes, n = 23 (clec-31 RNAi) nematodes, n = 22 (Rapamycin) nematodes. For i, n = 109 nematodes per group. For l, n = 27 (WT control) nematodes, n = 24 (clec-31-OE) nematodes. Three (a, d, e–l) or four (b, c) biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from one-way ANOVA with Dunnett’s multiple comparisons test (a, h), Two-tailed unpaired Student’s t-tests (b, c, f, g, j–l), one-way ANOVA with Tukey’s multiple comparisons test (d), Log-rank (Mantel-Cox) test (e, i). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 9 clec-31 regulates senescence and longevity through regulating autophagy. a, e Survival curves of (a) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, e clec-31-OE nematodes treated with or without rapamycin from day 1 of adulthood. All lines were raised and maintained at 20 °C. b, f The number of body bends monitored during a 30 s interval in (b) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, f clec-31-OE nematodes treated with or without rapamycin. c, g The number of pumps monitored during a 30 s interval in (c) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, g clec-31-OE nematodes treated with or without rapamycin. d, h Detection of lipofuscin autofluorescence in (d) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, h clec-31-OE nematodes treated with or without rapamycin. Bar = 100 μm. i–k Survival curves of (i) nematodes fed RNAi bacteria targeting empty vector, clec-31 or unc-51, alone or in combination, j nematodes fed RNAi bacteria targeting empty vector, clec-31 or vps34, alone or in combination, k clec-31-OE nematodes fed RNAi bacteria targeting empty vector, unc-51 or vps34 in the presence of rapamycin. All lines were raised and maintained at 20 °C. For a, e, i, j, k, n = 100 nematodes per group. For b, c, f, g, n = 30 nematodes per group. For d, n = 20 (WT+control RNAi, WT+let-363 RNAi or clec-31-OE+control RNAi) nematodes, n = 21 (clec-31-OE+let-363 RNAi) nematodes. For h, n = 30 (clec-31-OE) nematodes, n = 29 (clec-31-OE+Rapamycin) nematodes. Three biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Log-rank (Mantel-Cox) test (a, e, i–k), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (b–d), Two-tailed unpaired Student’s t-tests (f–h). Source data are provided as a Source data file.
Fig. 9 clec-31 regulates senescence and longevity through regulating autophagy. a, e Survival curves of (a) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, e clec-31-OE nematodes treated with or without rapamycin from day 1 of adulthood. All lines were raised and maintained at 20 °C. b, f The number of body bends monitored during a 30 s interval in (b) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, f clec-31-OE nematodes treated with or without rapamycin. c, g The number of pumps monitored during a 30 s interval in (c) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, g clec-31-OE nematodes treated with or without rapamycin. d, h Detection of lipofuscin autofluorescence in (d) WT and clec-31-OE nematodes fed RNAi bacteria targeting empty vector or let-363, h clec-31-OE nematodes treated with or without rapamycin. Bar = 100 μm. i–k Survival curves of (i) nematodes fed RNAi bacteria targeting empty vector, clec-31 or unc-51, alone or in combination, j nematodes fed RNAi bacteria targeting empty vector, clec-31 or vps34, alone or in combination, k clec-31-OE nematodes fed RNAi bacteria targeting empty vector, unc-51 or vps34 in the presence of rapamycin. All lines were raised and maintained at 20 °C. For a, e, i, j, k, n = 100 nematodes per group. For b, c, f, g, n = 30 nematodes per group. For d, n = 20 (WT+control RNAi, WT+let-363 RNAi or clec-31-OE+control RNAi) nematodes, n = 21 (clec-31-OE+let-363 RNAi) nematodes. For h, n = 30 (clec-31-OE) nematodes, n = 29 (clec-31-OE+Rapamycin) nematodes. Three biologically independent experiments. Data are shown as mean ± s.d.; P values are derived from Log-rank (Mantel-Cox) test (a, e, i–k), one-way ANOVA with Dunnett’s multiple comparisons test and Two-tailed unpaired Student’s t-tests (b–d), Two-tailed unpaired Student’s t-tests (f–h). Source data are provided as a Source data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Price, E. A., Coombe, D. R. & Murray, J. C. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int. J. Cancer 65, 513–518 (1996). · doi:10.1002/(sici)1097-0215(19960208)65:4<513::aid-ijc20>3.0.co;2-9

Cited by

See all 53

Metadata

Authors
Zhang, L., Yang, P., Chen, J., Chen, Z., Liu, Z., Feng, G., Sha, F., Li, Z., Xu, Z., Huang, Y., Shi, X., Li, X., Cui, J., Zhang, C., Fan, P., Cui, L., Shen, Y., Zhou, G., Jing, H., & Ma, S.
Affiliations
Henan University of Technology (CN)
Corresponding author
Zhang, Lu
Venue
Nature Communications
Published
2023-09-08
Volume
14
Issue
1
Pages
5524-5524
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4386544205
Cited by
45
References
43
Citations by year
2026: 11 · 2025: 24 · 2024: 10
FWCI
8.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (32070742)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
CD44, autophagy, vascular aging, vascular endothelial cells, PIK3C3, STAT3, premature aging, Caenorhabditis elegans
MeSH terms
Aging, Animals, Autophagy, Endothelium, Vascular, Humans, Caenorhabditis elegans, Hyaluronan Receptors, Aging, Premature, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD44 connects autophagy decline and ageing in the vascular endothelium. https://app.cochat.ai/papers/10.1038/s41467-023-41346-y
The paper
Zhang, L., Yang, P., Chen, J., Chen, Z., Liu, Z., Feng, G., Sha, F., Li, Z., Xu, Z., Huang, Y., Shi, X., Li, X., Cui, J., Zhang, C., Fan, P., Cui, L., Shen, Y., Zhou, G., Jing, H., & Ma, S. (2023). CD44 connects autophagy decline and ageing in the vascular endothelium. Nature Communications. https://doi.org/10.1038/s41467-023-41346-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.